Torrent Pharmaceuticals Ltd
Receipt of final listing and Trading approval for Equity shares of the Company issued and allotted in terms of Scheme of Amalgamation
M&A
▲ Positive Development
LOW RISK
📅 Filed on BSE: 27 Jul 2026, 07:00 PM IST · BSE ID: fd3913d2-a6b2-46a9-b4b1-100255b1e250
View Original BSE Filing (PDF)
💡
In Simple Terms
Torrent Pharma's new shares from the JB Chemicals merger are now approved for listing and will trade from July 28, 2026.
🤖 AI Summary
- Torrent Pharmaceuticals received final listing approval for 4,19,22,416 new equity shares on July 27, 2026.
- Shares were issued to eligible shareholders of J. B. Chemicals & Pharmaceuticals Limited per the amalgamation scheme.
- Each new equity share has a face value of ₹ 5/-.
- The new shares will commence trading on NSE and BSE effective July 28, 2026.
- This follows the effective date of the amalgamation on July 8, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Equity shares issued
4,19,22,416
Face value per share
₹ 5/-
Record Date for allotment
Friday, 17th July, 2026
Listing/Trading effective date
28th July, 2026
🏢 How This Affects the Company
The completion of the listing process for new shares formalizes the integration of J. B. Chemicals & Pharmaceuticals Limited into Torrent Pharmaceuticals, consolidating its market position.
This step integrates the financial structure post-amalgamation, including the issued equity capital reflecting the combined entity's shareholder base.
The operational aspects of the merger are now fully supported by the complete integration of capital markets requirements.
The final listing approval reduces execution risk related to the amalgamation process and ensures regulatory compliance.
👥 What This Means For Shareholders
✅
Action Required
No direct action is required from existing Torrent Pharmaceuticals shareholders related to this specific approval.
👤
Who Is Affected
Shareholders of the erstwhile J. B. Chemicals & Pharmaceuticals Limited who received 4,19,22,416 new equity shares of Torrent Pharmaceuticals will now see these shares admitted for trading on NSE and BSE.
🔍
Management Signal
The management's communication indicates a commitment to completing the amalgamation process and fulfilling all regulatory requirements promptly.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q1 FY27 financial results — assess impact of combined operations on financials.
Integration updates — monitor for further details on J. B. Chemicals operational merger.
Management commentaries — check for strategic outlook on the enlarged entity.
LOW RISK
The filing confirms completion of a regulatory step in a previously announced merger, reducing uncertainty.
💡 Investor Takeaway
Torrent Pharmaceuticals received final listing and trading approval on July 27, 2026, for 4,19,22,416 new equity shares of ₹ 5/- each, issued following the J. B. Chemicals amalgamation, with trading commencing on July 28, 2026.
⚖️ Strengths & Concerns
✅ Positives
- Successful completion of post-merger regulatory steps, ensuring smooth integration of the J. B. Chemicals & Pharmaceuticals entity.
- The listing of 4,19,22,416 new equity shares confirms the final capital structure post-amalgamation as planned.
📅 Company Track Record
Torrent Pharma's amalgamation with J. B. Chemicals & Pharmaceuticals Limited became effective on July 8, 2026, following NCLT sanction on July 6, 2026. A record date of July 17, 2026, was set for share exchange, leading to the allotment of 4,19,22,416 equity shares.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What is the status of the new equity shares issued by Torrent Pharmaceuticals?
Torrent Pharmaceuticals received final listing and trading approval for 4,19,22,416 new fully paid-up Equity shares from NSE and BSE on July 27, 2026.
When will the new equity shares of Torrent Pharmaceuticals start trading?
The 4,19,22,416 new Equity shares of Torrent Pharmaceuticals will be listed and admitted to dealings on the Exchanges (NSE and BSE) effective July 28, 2026.
What was the face value of the new equity shares issued by Torrent Pharmaceuticals?
The new equity shares issued by Torrent Pharmaceuticals have a face value of ₹ 5/- each.
How many new equity shares were issued by Torrent Pharmaceuticals for the amalgamation?
Torrent Pharmaceuticals issued and allotted 4,19,22,416 new fully paid-up Equity shares in terms of the Scheme of Amalgamation with J. B. Chemicals & Pharmaceuticals Limited.
Questions based on this BSE filing only. For information purposes.